A Phase II Single-centered Randomized Controlled Trials of Concurrent Chemoradiotherapy with S-1 Plus Cisplatin Compared to 5-fluorouracil Plus Cisplatin in Non-operable Esophageal Carcinoma.

Trial Profile

A Phase II Single-centered Randomized Controlled Trials of Concurrent Chemoradiotherapy with S-1 Plus Cisplatin Compared to 5-fluorouracil Plus Cisplatin in Non-operable Esophageal Carcinoma.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Nov 2016

At a glance

  • Drugs Fluorouracil (Primary) ; Gimeracil/oteracil/tegafur (Primary) ; Cisplatin
  • Indications Oesophageal cancer
  • Focus Therapeutic Use
  • Sponsors Shandong New age Pharmaceutical
  • Most Recent Events

    • 19 Jul 2015 Status changed from not yet recruiting to completed.
    • 21 May 2012 Planned end date changed from 1 Oct 2013 to 31 Oct 2016 as reported by Chinese Clinical Trial Register.
    • 05 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top